Literature DB >> 15072594

Targeted disruption of one allele of the Y-box binding protein-1 (YB-1) gene in mouse embryonic stem cells and increased sensitivity to cisplatin and mitomycin C.

Kotaro Shibahara1, Takeshi Uchiumi, Takao Fukuda, Shinobu Kura, Yohei Tominaga, Yoshihiko Maehara, Kimitoshi Kohno, Yusaku Nakabeppu, Teruhisa Tsuzuki, Michihiko Kuwano.   

Abstract

The eukaryotic Y-box binding protein-1 (YB-1) functions in various biological processes, including transcriptional and translational control, DNA repair, drug resistance, and cell proliferation. To elucidate the physiological role of the YB-1 protein, we disrupted one allele of mouse YB-1 in embryonic stem (ES) cells. Northern blot analysis revealed that YB-1(+/-) ES cells with one intact allele contain approximately one-half the amount of mRNA detected in wild-type (YB-1(+/+)) cells. We further found that the protein level of YB-1(+/-) cells was reduced to approximately 50-60% compared with that of YB-1(+/+) cells. However, no apparent growth difference was found between YB-1(+/-) and YB-1(+/+) cells. YB-1(+/-) cells showed increased sensitivity to cisplatin and mitomycin C, but not to etoposide, X-ray or UV irradiation, as compared to YB-1(+/+) cells. YB-1 may have the capacity to exert a protective role against cytotoxic effects of DNA damaging agents, and may be involved in certain aspects of drug resistance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15072594     DOI: 10.1111/j.1349-7006.2004.tb03214.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  19 in total

1.  Cotranscriptional exon skipping in the genotoxic stress response.

Authors:  Martin Dutertre; Gabriel Sanchez; Marie-Cécile De Cian; Jérôme Barbier; Etienne Dardenne; Lise Gratadou; Gwendal Dujardin; Catherine Le Jossic-Corcos; Laurent Corcos; Didier Auboeuf
Journal:  Nat Struct Mol Biol       Date:  2010-10-24       Impact factor: 15.369

2.  An acidic protein, YBAP1, mediates the release of YB-1 from mRNA and relieves the translational repression activity of YB-1.

Authors:  Ken Matsumoto; Kimio J Tanaka; Masafumi Tsujimoto
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

3.  YB-1 is important for late-stage embryonic development, optimal cellular stress responses, and the prevention of premature senescence.

Authors:  Zhi Hong Lu; Jason T Books; Timothy J Ley
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

4.  Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1.

Authors:  Ranajoy Chattopadhyay; Soumita Das; Amit K Maiti; Istvan Boldogh; Jingwu Xie; Tapas K Hazra; Kimitoshi Kohno; Sankar Mitra; Kishor K Bhakat
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

5.  Interaction network analysis of YBX1 for identification of therapeutic targets in adenocarcinomas.

Authors:  Suriya Narayanan Murugesan; Birendra Singh Yadav; Pramod Kumar Maurya; Amit Chaudhary; Swati Singh; Ashutosh Mani
Journal:  J Biosci       Date:  2019-06       Impact factor: 1.826

6.  YBX1 expression and function in early hematopoiesis and leukemic cells.

Authors:  Jasjeet Bhullar; Vincent E Sollars
Journal:  Immunogenetics       Date:  2011-03-03       Impact factor: 2.846

7.  The N-terminal domain of y-box binding protein-1 induces cell cycle arrest in g2/m phase by binding to cyclin d1.

Authors:  Payal Khandelwal; Mythili K Padala; John Cox; Ramareddy V Guntaka
Journal:  Int J Cell Biol       Date:  2010-04-14

8.  Global survey of protein expression during gonadal sex determination in mice.

Authors:  Katherine Ewen; Mark Baker; Dagmar Wilhelm; R John Aitken; Peter Koopman
Journal:  Mol Cell Proteomics       Date:  2009-07-17       Impact factor: 5.911

9.  Y-box binding protein 1 (YB-1) promotes gefitinib resistance in lung adenocarcinoma cells by activating AKT signaling and epithelial-mesenchymal transition through targeting major vault protein (MVP).

Authors:  Lei Lou; Juan Wang; Fengzhu Lv; Guohui Wang; Yuehong Li; Lingxiao Xing; Haitao Shen; Xianghong Zhang
Journal:  Cell Oncol (Dordr)       Date:  2020-09-07       Impact factor: 6.730

10.  Cisplatin induces differentiation in teratomas derived from pluripotent stem cells.

Authors:  Atsushi Kurata; Masakatsu Takanashi; Shin-Ichiro Ohno; Koji Fujita; Masahiko Kuroda
Journal:  Regen Ther       Date:  2021-06-08       Impact factor: 3.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.